A genetically engineered single-chain FVTNF molecule possesses the anti-tumor immunoreactivity of FV as well as the cytotoxic activity of tumor necrosis factor

This publication has 20 references indexed in Scilit:

• Use of bacteriophage T7 RNA polymerase to direct selective high-level expression of cloned genes
  Published by Elsevier ,2004
• Single‐chain antibody variable region‐targeted interleukin‐2 stimulates T cell killing of human colorectal carcinoma cells
  Immunology & Cell Biology, 1994
• Recombinant Bifunctional Molecule FV/IFN-γ Possesses the Anti-Tumor FV as Well as the Gamma Interferon Activities
  Cancer Biotherapy, 1993
• Tumor suppression after tumor cell-targeted tumor necrosis factor alpha gene transfer.
  The Journal of Experimental Medicine, 1991
• Intralesional application of recombinant human tumor necrosis factor alpha induces local tumor regression in patients with advanced malignancies
  European Journal of Cancer and Clinical Oncology, 1989
• Recombinant Human Tumor Necrosis Factor Administered as a 24-Hour Intravenous Infusion. A Phase I and Pharmacologic Study
  JNCI Journal of the National Cancer Institute, 1988
• Inhibition of cytotoxic T cell development by transforming growth factor beta and reversal by recombinant tumor necrosis factor alpha.
  The Journal of Experimental Medicine, 1987
• Tumour necrosis factor as immunomodulator and mediator of monocyte cytotoxicity induced by itself, γ-interferon and interleukin-1
  Nature, 1986
• Recombinant Human Tumor Necrosis Factor-α: Effects on Proliferation of Normal and Transformed Cells in Vitro
  Science, 1985
• Antitumor activity of murine tumor necrosis factor (TNF) against transplanted murine tumors and heterotransplanted human tumors in nude mice
  International Journal of Cancer, 1984